Juvena Therapeutics | $33,500,000 | (Jan 14, 2026)
bricks.sh | $1,863,303 | (Jan 14, 2026)
Allos | $5,000,000 | (Jan 14, 2026)
Certified by Founder
Lodge
EnPlusOne Biosciences
start up
United States
- Watertown, Massachusetts
- 21/02/2025
- Unknown
- $10,000,000
EnPlusOne is on a mission to bring RNA and RNA solutions to the world. Its ezRNA™ synthesis platform is a stepwise innovation that can incorporate a diverse array of nucleotide modifications and promises a manufacturing process that can sustainably deliver therapeutic RNA at commercial scales. In addition to direct RNA synthesis, EnPlusOne's ezRNA™ platform supports a vast array of RNA solution applications. For more information, please visit www.enplusonebio.com
- Industry Biotechnology Research
- Website https://www.enplusonebio.com/
- LinkedIn https://www.linkedin.com/company/enplusone-bio/
Related People
Daniel AhlstedtCo Founder
United States -
Boston, Massachusetts
Experienced biotechnology process engineer with a demonstrated history of supporting manufacturing operations, equipment design, and start-up of large capital projects while adhering to FDA and international regulations.
PayMedix | $33,000,000 | (Jan 14, 2026)
WeatherPromise | $12,800,000 | (Jan 14, 2026)
Diffraqtion | $4,200,000 | (Jan 14, 2026)
WithCoverage | $42,000,000 | (Jan 14, 2026)
Nodu | $1,450,000 | (Jan 14, 2026)
Cloudforce | $10,000,000 | (Jan 14, 2026)
Converge Bio | $25,000,000 | (Jan 14, 2026)
JetZero | $175,000,000 | (Jan 14, 2026)
TRYBE | $30,000,000 | (Jan 13, 2026)